Peering Into Becton Dickinson’s Recent Short Interest
Becton Dickinson’s (NYSE:BDX) short percent of float has fallen 9.33% since its last report. The company recently reported…
BD Bolsters Portfolio With $4.2B Cash Deal For Edwards Lifesciences’ Critical Care Group: Details
BD (Becton, Dickinson and Company) will acquire Edwards Lifesciences' Critical Care product group for $4.2 billion in cash. This acquisition enhances BD's portfolio with advanced AI-enabled monitoring technologies, aiming to improve patient outcomes in critical care settings. The transaction is expected to boost BD's financial performance, delivering immediate accretive benefits and long-term revenue growth.
Biden’s New Tariffs On Chinese Imports Are A ‘Clear Giveaway’ To These Two Tesla Rivals, Jim Cramer Says: ‘I Like This Policy’
Jim Cramer has highlighted the potential benefits for U.S. automakers, particularly Ford and General Motors, following the Biden administration's decision to impose substantial tariffs on Chinese imports.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…
Becton & Dickinson ‘Is Well On Its Way To Achieving 2025 Commitments,’ Analyst Optimistic On Outlook
BD reports Q2 sales of $5.04 billion, up 4.6% Y/Y. BD Medical, Life Sciences, and Interventional segments show growth. Guidance was raised for 2024 sales, and EPS was adjusted. William Blair rates BDX shares Outperform.
Looking Into Becton Dickinson’s Recent Short Interest
Becton Dickinson’s (NYSE:BDX) short percent of float has risen 4.12% since its last report. The company recently reported…
AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement
AngioDynamics resolves decade-long patent litigation with Becton, Dickinson in landmark settlement, streamlining legal expenses and marking a significant milestone for the company.
Peering Into Becton Dickinson’s Recent Short Interest
Becton Dickinson’s (NYSE:BDX) short percent of float has risen 34.72% since its last report. The company recently reported…
Becton Dickinson Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Across the recent three months, 5 analysts have shared their insights on Becton Dickinson (NYSE:BDX), expressing a variety…
Medical Device Maker Becton Dickinson’s Q1 Earnings: Here’s Why This Analyst Is Bullish On Long-Term Prospects
BD exceeds expectations with Q1 2024 adjusted EPS of $2.68 (vs $2.40 consensus). William Blair maintains a positive outlook, confident in BD's progress towards its 2025.